If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sabrina Cecere is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Platinum Medicine & Life Sciences
trabectedin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Kidney Neoplasms Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 598 Citations
  • 14 h-Index
  • 68 Article
  • 3 Review article
  • 2 Chapter

Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

Lorusso, D., Ferrandina, G., Colombo, N., Pignata, S., Pietragalla, A., Sonetto, C., Pisano, C., Lapresa, M. T., Savarese, A., Tagliaferri, P., Lombardi, D., Cinieri, S., Breda, E., Sabatucci, I., Sabbatini, R., Conte, C., Cecere, S. C., Maltese, G. & Scambia, G., 2019, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Endometrial Neoplasms
Disease-Free Survival
Combination Drug Therapy

Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome

Cecere, S. C., Giannone, G., Salutari, V., Arenare, L., Lorusso, D., Ronzino, G., Lauria, R., Cormio, G., Carella, C., Scollo, P., Ghizzoni, V., Raspagliesi, F., Di Napoli, M., Mazzoni, E., Marchetti, C., Bergamini, A., Orditura, M., Valabrega, G., Scambia, G., Maltese, G. & 7 others, De Matteis, E., Cardalesi, C., Loizzi, V., Boccia, S., Naglieri, E., Scandurra, G. & Pignata, S., Jan 1 2019, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Drug Therapy

Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F. & 8 others, Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C. & Pignata, S., 2019, In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Drug Therapy
Uterine Cervical Neoplasms
Disease-Free Survival
Epidermal Growth Factor Receptor

Treatment of recurrent epithelial ovarian cancer

Pignata, S., Pisano, C., Di Napoli, M., Cecere, S. C., Tambaro, R. & Attademo, L., Dec 15 2019, In : Cancer. 125, S24, p. 4609-4615 7 p.

Research output: Contribution to journalReview article

Open Access